Abstract
Objective Exacerbated autonomic responses to acute stress are prevalent in posttraumatic stress disorder (PTSD). The purpose of this study was to assess the effects of transcutaneous cervical VNS (tcVNS) on autonomic responses to acute stress in patients with PTSD. The authors hypothesized tcVNS would reduce the sympathetic response to stress compared to a sham device.
Methods Using a randomized double-blind approach, we studied the effects of tcVNS on physiological responses to stress in patients with PTSD (n=25) using noninvasive sensing modalities. Participants received either sham or active tcVNS after exposure to acute personalized traumatic script stress and mental stress (public speech, mental arithmetic) over a three-day protocol. Physiological parameters related to sympathetic responses to stress were investigated.
Results Relative to sham, tcVNS paired to traumatic script stress decreased sympathetic function as measured by: decreased heart rate (adjusted ß=-5.7%; 95% CI: ±3.6%, effect size d=0.43, p<0.01), increased photoplethysmogram amplitude (peripheral vasodilation) (30.8%; ±28%, 0.29, p<0.05), and increased pulse arrival time (vascular function) (6.3%; ±1.9%, 0.57, p<0.0001). Similar (p < 0.05) autonomic, cardiovascular, and vascular effects were observed when tcVNS was applied after mental stress or without acute stress.
Conclusion tcVNS attenuates sympathetic arousal associated with stress related to traumatic memories as well as mental stress in patients with PTSD, with effects persisting throughout multiple traumatic stress and stimulation testing days. These findings show that tcVNS has beneficial effects on the underlying neurophysiology of PTSD. Such autonomic metrics may also be evaluated in daily life settings in tandem with tcVNS therapy to provide closed-loop delivery and measure efficacy.
ClinicalTrials.gov Registration # NCT02992899
HighlightsWe studied the effects of tcVNS on physiological responses to stress in patients posttraumatic stress disorder (PTSD).
tcVNS modulates physiologic reactivity to traumatic and mental stress in PTSD, and modulates autonomic tone when applied without acute stress.
Repeated tcVNS enhances resilience in the face of repeated stress in PTSD as quantified by peripheral autonomic measures which potentially could serve as real-time measures to evaluate the therapy response in longitudinal settings.
Competing Interest Statement
JDB is currently conducting research on noninvasive vagus nerve stimulation with applications to posttraumatic stress disorder with research support from an investigator-initiated research contract with ElectroCore LLC and a Distinguished Investigator Award from the Brain and Behavior Research Foundation (BBRF) / National Alliance for Research on Schizophrenia and Affective Disorders (NARSAD). There are no other relevant royalty, advisory board, consulting, patents, or stock ownership to disclose.
Clinical Trial
NCT02992899
Clinical Protocols
https://doi.org/10.1016/j.brs.2019.08.002
Funding Statement
This work was supported by the Defense Advanced Research Projects Agency (DARPA), Arlington, VA, under Cooperative Agreement N66001-16-2-4054. Dr. Shah is sponsored by the National Institutes of Health, Award K23 HL127251.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Acknowledgments: This work was supported by the Defense Advanced Research Projects Agency (DARPA), Arlington, VA, under Cooperative Agreement N66001-16-2-4054. Dr. Shah is sponsored by the National Institutes of Health, Award K23 HL127251. We would like to acknowledge and thank Margie Jones, CNMT, Steven Rhodes, RN, and Javier Hernandez, PhD (Microsoft Research) for their assistance with clinical research and affective computing discussions.
Disclosures: JDB is currently conducting research on noninvasive vagus nerve stimulation with applications to posttraumatic stress disorder with research support from an investigator-initiated research contract with ElectroCore LLC and a Distinguished Investigator Award from the Brain and Behavior Research Foundation (BBRF) / National Alliance for Research on Schizophrenia and Affective Disorders (NARSAD). There are no other relevant royalty, advisory board, consulting, patents, or stock ownership to disclose.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos